Immunotherapy significantly improves overall survival for advanced NSCLC patients

FHS
July 7, 2023
3:13 am

A global study, led by UCL and UCLH and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer patients who were not able to be treated with platinum-containing chemotherapy, when compared to single-agent chemotherapy.

3 Denver Botanic Gardens shows are transforming the ordinary – The Cannabist

Denver Botanic Gardens sets a fine example for its cultural peers by including space for art shows at its main headquarters on York Street. It’s

September 2, 2024

Biopharma’s 20 highest-paid CEOs of 2023, earning $20M+ pay packages

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 10, 2024

BSIM Healthcare Services to Deploy Innovaccer’s AI Platform

What You Should Know: – Innovaccer Inc., a healthcare artificial intelligence (AI) company, today announced a significant partnership with BSIM Healthcare Services. – BSIM, dedicated

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.